期刊文献+

HPLC同时测定复方替米沙坦片中主成分含量 被引量:1

Simultaneous Determination of Main Components in Compound Telmisartan Tablets by HPLC
下载PDF
导出
摘要 目的:建立复方替米沙坦片中两种药物含量测定的HPLC法。方法:采用菲罗门Cia色谱柱(150 mm×4.6 mm,5Rm),以50 mmol·L^(-1)磷酸二氢钠溶液(pH 6.0,0.5%三乙胺)-乙腈(40:60,v/v)为流动相,流速1.0 ml·min^(-1),测波长254 nm,柱温30℃进样量20μl。结果:替米沙坦与苯磺酸氨氯地平可达到较好分离潜米沙坦的质量浓度在4.0~80.0μg·ml^(-1)内(r=0.9999),苯磺酸氨氯地平质量浓度在1.0-20.0μg·ml^(-1)(r=0.999 9)内与峰面积呈良好的线性关系。替米沙坦和苯磺酸氨氯地平的平均回收率分别为99.90%和100.52%(n=9),RSD分别为0.74%和1.48%(n=9)。结论:该方法专属性强、稳定准确适用于复方替米沙坦片的含量测定。 Objective: To establish an HPLC method for the simultaneous determination of telmisartan and amlodipine besylate in tablets. Methods: The isocratic separation was achieved on a Phenomenex C18 column (150 mm× 4.6 mm, 5 μm) with the mobile phase composed of 50 mmol L-1 sodium dihydrogen phosphate buffer ( pH 6.0, 0.5% triethylamine) -acetonitrile (40: 60, v/v). The flow rate was 1.0 ml min - 1 , the detection wavelength was 254 nm, the column temperature was 30℃ and the sample size was 20 μl. Results: Telmisartan could be well separated from amlodipine besylate under the conditions mentioned above. The linearity be- tween the peak area and the concentration was obtained within the range of 4.0-80.0 μg ml - 1 ( r = 0.999 9 ) for telmisartan and 1.0- 20.0 μg ml- 1 (r = 0.999 9) for amlodipine besylate. The mean recovery of telmisartan and amlodipine besylate was 99.90% and 100.52%, and RSD was 0.74% and 1.48%, respectively ( n = 9). Conclusion : The method is specific, stable and accurate in the determination of compound telmisartan tablets.
出处 《中国药师》 CAS 2015年第12期2171-2172,2179,共3页 China Pharmacist
关键词 替米沙坦 苯磺酸氨氯地平 含量测定 高效液相色谱 Telmisartan Amlodipine besylate Determination HPLC
  • 相关文献

参考文献14

二级参考文献26

  • 1吴海明.氨氯地平联合替米沙坦治疗高血压疗效分析[J].医学信息(医学与计算机应用),2014,0(6):359-359. 被引量:2
  • 2朱志林,王静,刘红,冷柏华,梅苑.老年高血压患者动态血压负荷值与靶器官损害相关性分析[J].临床心血管病杂志,2005,21(5):311-312. 被引量:40
  • 3荆珊,孙宁玲,柯元南,杨新春,何汝敏,吴宗贵,严晓伟,姚晨.奥美沙坦酯片治疗轻中度原发性高血压的疗效和安全性[J].中国临床药理学杂志,2006,22(1):3-6. 被引量:25
  • 4中国高血压防治指南修订委员会.中国高血压防治指南标准(2005年修订版)[J].Chin J Hyertens,2005,13(1):1-53.
  • 5Hany W. Darwish,Ahmed H. Backeit.Multivariate Versus Classical Univariate Calibration Methods for Spectrofluorimetric Data: Application to Simultaneous Determination of Olmesartan Medoxamil and Amlodipine Besylate in their Combined Dosage Form[J]. Journal of Fluorescence . 2013 (1)
  • 6Reinhold Kreutz.Olmesartan/amlodipine: a review of its use in the management of hypertension[J]. Vascular Health and Risk Management . 2011 (default)
  • 7Alan H. Gradman,Jan N. Basile,Barry L. Carter,George L. Bakris.Combination therapy in hypertension[J]. Journal of the American Society of Hypertension . 2010 (2)
  • 8K.R. Patil,V.P. Rane,J.N. Sangshetti,R.D. Yeole,D.B. Shinde.Stability Indicating LC Method For the Simultaneous Determination of Amlodipine and Olmesartan in Dosage Form[J]. Journal of Chromatographic Science . 2010 (7)
  • 9Greathouse Mark.Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension. Vascular health and risk management . 2007
  • 10SYED SHANAZ QUTAB,SYED NAEEM RAZZAQ,MUHAMMAD ASHFAQ,ISLAM ULLAH KHAN,AHMAD MAHMOOD MUMTAZ.SIMULTANEOUS QUANTITATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE IN COMBINED TABLETS USING HPLC. J. Chil. Chem. Soc . 2009

共引文献27

同被引文献17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部